Wuhan YZY Biopharma Co., Ltd. Class H(HK:2496)
HK$4.200.00 (0.00%)
HK:2496
Wuhan YZY Biopharma Co., Ltd. Class H financials statements
HK$4.20
At close:0.00 (0.00%)
Want to see HK:2496 full AI Analyst Report?
Wuhan YZY Biopharma Co., Ltd. Class H (2496) Income Statement
1 Followers
Wuhan YZY Biopharma Co., Ltd. Class H Income Statement
Last quarter (Q2 2026), Wuhan YZY Biopharma Co., Ltd. Class H's total revenue was ¥32.69M, an increase of 47.33% from the same quarter last year. In Q2, Wuhan YZY Biopharma Co., Ltd. Class H's net income was ¥-6.17M. See Wuhan YZY Biopharma Co., Ltd. Class H’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ¥ 65.13M | ¥ 107.81M | ¥ 11.92M | ¥ 2.28M | ¥ 12.18M | |
| ¥ 6.17M | ¥ 85.07M | ¥ 11.92M | ¥ 2.28M | ¥ 12.18M | |
| ¥ 94.11M | ¥ 183.07M | ¥ 177.37M | ¥ 177.85M | ¥ 144.39M | |
| Depreciation and Amortization | ¥ 4.44M | ¥ 6.57M | ¥ 7.32M | ¥ 6.94M | ¥ 7.62M |
| ¥ -83.49M | ¥ -86.95M | ¥ -157.46M | ¥ -168.63M | ¥ -124.61M | |
| ¥ -87.93M | ¥ -98.00M | ¥ -177.37M | ¥ -175.58M | ¥ -132.23M | |
| ¥ 5.39M | ¥ 402.00K | ¥ -14.34M | ¥ -13.29M | ¥ -16.29M | |
| ¥ -82.54M | ¥ -97.60M | ¥ -190.98M | ¥ -188.87M | ¥ -148.52M | |
| ¥ -82.54M | ¥ -97.60M | ¥ -190.98M | ¥ -188.87M | ¥ -148.52M | |
| Per Share Metrics | |||||
| Basic EPS | ¥ -0.42 | ¥ -0.50 | ¥ -1.14 | ¥ -0.98 | ¥ -0.77 |
| Diluted EPS | ¥ -0.42 | ¥ -0.50 | ¥ -1.14 | ¥ -0.98 | ¥ -0.77 |
| Weighted Average Shares Outstanding | 193.85M | 193.85M | 185.11M | 193.00M | 193.00M |
| Weighted Average Shares Outstanding (Diluted) | 193.85M | 193.85M | 185.11M | 193.00M | 193.00M |
Currency in CNY

